Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://fdoctor.ru
Are you over 18 and want to see adult content?
A complete backup of https://mortongroveil.org
Are you over 18 and want to see adult content?
A complete backup of https://anamanaguchi.com
Are you over 18 and want to see adult content?
A complete backup of https://mangroveactionproject.org
Are you over 18 and want to see adult content?
A complete backup of https://lugaru.com
Are you over 18 and want to see adult content?
A complete backup of https://joopea.com
Are you over 18 and want to see adult content?
A complete backup of https://despreker.nl
Are you over 18 and want to see adult content?
A complete backup of https://filevine.com
Are you over 18 and want to see adult content?
A complete backup of https://hellweg.de
Are you over 18 and want to see adult content?
A complete backup of https://swfound.org
Are you over 18 and want to see adult content?
A complete backup of https://gameplay.pl
Are you over 18 and want to see adult content?
A complete backup of https://moissanite.com
Are you over 18 and want to see adult content?
Favourite Annotations
Scientific Testimony - An Online Journal
Are you over 18 and want to see adult content?
SD-WAN Innovator and Leader | Talari Networks
Are you over 18 and want to see adult content?
Familienurlaub – Urlaub mit Kindern günstig bei Club Family buchen
Are you over 18 and want to see adult content?
Trexin Consulting | Specializing in Strategy Execution
Are you over 18 and want to see adult content?
A complete backup of vapearound.co.nz
Are you over 18 and want to see adult content?
Bexion Pharmaceutical – Creating Cures for Cancer
Are you over 18 and want to see adult content?
Text
is
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up. NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and MindtechACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up. NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and MindtechACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech PRAGMATIC SEMICONDUCTOR SELECTED AS ONE OF THE FINALISTS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc CAREERS - CAMBRIDGE INNOVATION CAPITAL - CIC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
CMR SURGICAL ANNOUNCES 1,000 SURGERIES COMPLETED BY 2020. 25 November 2020. CMR Surgical announces 1,000 surgeries completed by Versius. Versius, the next-generation surgical robot has been used to successfully conduct over 1,000 surgical procedures in hospitals across Europe and Asia. Combining Versius with a wider digital ecosystem, including a clinical registry, opens the door toworking with
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy CAMBRIDGE INNOVATION CAPITAL ANNOUNCES ACQUISITION OF Cambridge Innovation Capital announces acquisition of portfolio company Inivata. Cambridge Innovation Capital (CIC), the venture capital investor focused on IP-rich deep technology and life science businesses in the Cambridge ecosystem, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research ASSOCIATE - TECHNOLOGY - CAMBRIDGE INNOVATION CAPITAL Associate – Technology. Employment type: Full time. Location: Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT, UK. About Cambridge Innovation Capital. Cambridge Innovation Capital (CIC) is a leading venture investor in Cambridge backing and building category-leadingdeep tech and
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up. NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and MindtechACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up. NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and MindtechACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech PRAGMATIC SEMICONDUCTOR SELECTED AS ONE OF THE FINALISTS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc CAREERS - CAMBRIDGE INNOVATION CAPITAL - CIC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
CMR SURGICAL ANNOUNCES 1,000 SURGERIES COMPLETED BY 2020. 25 November 2020. CMR Surgical announces 1,000 surgeries completed by Versius. Versius, the next-generation surgical robot has been used to successfully conduct over 1,000 surgical procedures in hospitals across Europe and Asia. Combining Versius with a wider digital ecosystem, including a clinical registry, opens the door toworking with
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy CAMBRIDGE INNOVATION CAPITAL ANNOUNCES ACQUISITION OF Cambridge Innovation Capital announces acquisition of portfolio company Inivata. Cambridge Innovation Capital (CIC), the venture capital investor focused on IP-rich deep technology and life science businesses in the Cambridge ecosystem, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research ASSOCIATE - TECHNOLOGY - CAMBRIDGE INNOVATION CAPITAL Associate – Technology. Employment type: Full time. Location: Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT, UK. About Cambridge Innovation Capital. Cambridge Innovation Capital (CIC) is a leading venture investor in Cambridge backing and building category-leadingdeep tech and
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up. NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and MindtechACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up. NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and MindtechACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech PRAGMATIC SEMICONDUCTOR SELECTED AS ONE OF THE FINALISTS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc CAREERS - CAMBRIDGE INNOVATION CAPITAL - CIC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
CMR SURGICAL ANNOUNCES 1,000 SURGERIES COMPLETED BY 2020. 25 November 2020. CMR Surgical announces 1,000 surgeries completed by Versius. Versius, the next-generation surgical robot has been used to successfully conduct over 1,000 surgical procedures in hospitals across Europe and Asia. Combining Versius with a wider digital ecosystem, including a clinical registry, opens the door toworking with
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy CAMBRIDGE INNOVATION CAPITAL ANNOUNCES ACQUISITION OF Cambridge Innovation Capital announces acquisition of portfolio company Inivata. Cambridge Innovation Capital (CIC), the venture capital investor focused on IP-rich deep technology and life science businesses in the Cambridge ecosystem, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research ASSOCIATE - TECHNOLOGY - CAMBRIDGE INNOVATION CAPITAL Associate – Technology. Employment type: Full time. Location: Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT, UK. About Cambridge Innovation Capital. Cambridge Innovation Capital (CIC) is a leading venture investor in Cambridge backing and building category-leadingdeep tech and
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech PRAGMATIC SEMICONDUCTOR SELECTED AS ONE OF THE FINALISTS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc CAREERS - CAMBRIDGE INNOVATION CAPITAL - CIC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
CMR SURGICAL ANNOUNCES 1,000 SURGERIES COMPLETED BY 2020. 25 November 2020. CMR Surgical announces 1,000 surgeries completed by Versius. Versius, the next-generation surgical robot has been used to successfully conduct over 1,000 surgical procedures in hospitals across Europe and Asia. Combining Versius with a wider digital ecosystem, including a clinical registry, opens the door toworking with
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy CAMBRIDGE INNOVATION CAPITAL ANNOUNCES ACQUISITION OF Cambridge Innovation Capital announces acquisition of portfolio company Inivata. Cambridge Innovation Capital (CIC), the venture capital investor focused on IP-rich deep technology and life science businesses in the Cambridge ecosystem, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research SENSE: KOCH PARTNER TO DEVELOP RAPID COVID-19 TEST Sense of urgency: Koch partnering to develop rapid COVID-19 test. Article by Koch Newsroom. Phillips-Medisize is helping Sense Biodetection produce a first-of-its-kind molecular diagnostic test that can be administered anywhere and provides a diagnosis in lessthan 10 minutes
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech PRAGMATIC SEMICONDUCTOR SELECTED AS ONE OF THE FINALISTS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc CAREERS - CAMBRIDGE INNOVATION CAPITAL - CIC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
CMR SURGICAL ANNOUNCES 1,000 SURGERIES COMPLETED BY 2020. 25 November 2020. CMR Surgical announces 1,000 surgeries completed by Versius. Versius, the next-generation surgical robot has been used to successfully conduct over 1,000 surgical procedures in hospitals across Europe and Asia. Combining Versius with a wider digital ecosystem, including a clinical registry, opens the door toworking with
CAMBRIDGE INNOVATION CAPITAL ANNOUNCES ACQUISITION OF Cambridge Innovation Capital announces acquisition of portfolio company Inivata. Cambridge Innovation Capital (CIC), the venture capital investor focused on IP-rich deep technology and life science businesses in the Cambridge ecosystem, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research ASSOCIATE - TECHNOLOGY - CAMBRIDGE INNOVATION CAPITAL Associate – Technology. Employment type: Full time. Location: Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT, UK. About Cambridge Innovation Capital. Cambridge Innovation Capital (CIC) is a leading venture investor in Cambridge backing and building category-leadingdeep tech and
STORM THERAPEUTICS PUBLISHES DATA IN NATURE SHOWING ITS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech PRAGMATIC SEMICONDUCTOR SELECTED AS ONE OF THE FINALISTS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc CAREERS - CAMBRIDGE INNOVATION CAPITAL - CIC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
CMR SURGICAL ANNOUNCES 1,000 SURGERIES COMPLETED BY 2020. 25 November 2020. CMR Surgical announces 1,000 surgeries completed by Versius. Versius, the next-generation surgical robot has been used to successfully conduct over 1,000 surgical procedures in hospitals across Europe and Asia. Combining Versius with a wider digital ecosystem, including a clinical registry, opens the door toworking with
CAMBRIDGE INNOVATION CAPITAL ANNOUNCES ACQUISITION OF Cambridge Innovation Capital announces acquisition of portfolio company Inivata. Cambridge Innovation Capital (CIC), the venture capital investor focused on IP-rich deep technology and life science businesses in the Cambridge ecosystem, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research ASSOCIATE - TECHNOLOGY - CAMBRIDGE INNOVATION CAPITAL Associate – Technology. Employment type: Full time. Location: Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT, UK. About Cambridge Innovation Capital. Cambridge Innovation Capital (CIC) is a leading venture investor in Cambridge backing and building category-leadingdeep tech and
STORM THERAPEUTICS PUBLISHES DATA IN NATURE SHOWING ITS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
ORIGAMI RAISES £20 MILLION IN SERIES C FUNDING ROUND LED Origami raises £20 million in Series C funding round led by Barclays. Latest investment will accelerate delivery of trading and automation technology for green energy ESG POLICY - CAMBRIDGE INNOVATION CAPITAL Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice. GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
NEW CAMBRIDGE ACCELERATOR FOR DEEPTECH STARTUPS LAUNCHES New Cambridge accelerator for deeptech startups launches with five machine learning investments. Deeptech Labs launches, backed by Arm, Cambridge Innovation Capital, Martlet Capital, Ewan Kirk, and the University of CambridgeThe accelerator and fund has announced its first cohort of AI/machine learning startups: AutoFill, BKwai, Circuit Mind, Contilio, and Mindtech PRAGMATIC SEMICONDUCTOR SELECTED AS ONE OF THE FINALISTS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc CAREERS - CAMBRIDGE INNOVATION CAPITAL - CIC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
INSIDE THE UNICORN FACTORY Inside the unicorn factory. PrivateEquity Wire article | by James Williams. An in-depth look at how Cambridge Innovation Capital is leveraging its position within the University of Cambridge’s ecosystem to seek out disruptive innovators in technology and lifescience.
CMR SURGICAL ANNOUNCES 1,000 SURGERIES COMPLETED BY 2020. 25 November 2020. CMR Surgical announces 1,000 surgeries completed by Versius. Versius, the next-generation surgical robot has been used to successfully conduct over 1,000 surgical procedures in hospitals across Europe and Asia. Combining Versius with a wider digital ecosystem, including a clinical registry, opens the door toworking with
CAMBRIDGE INNOVATION CAPITAL ANNOUNCES ACQUISITION OF Cambridge Innovation Capital announces acquisition of portfolio company Inivata. Cambridge Innovation Capital (CIC), the venture capital investor focused on IP-rich deep technology and life science businesses in the Cambridge ecosystem, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research ASSOCIATE - TECHNOLOGY - CAMBRIDGE INNOVATION CAPITAL Associate – Technology. Employment type: Full time. Location: Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT, UK. About Cambridge Innovation Capital. Cambridge Innovation Capital (CIC) is a leading venture investor in Cambridge backing and building category-leadingdeep tech and
STORM THERAPEUTICS PUBLISHES DATA IN NATURE SHOWING ITS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes CAREERS - CAMBRIDGE INNOVATION CAPITAL - CICCAMBRIDGE INNOVATION CENTREUNITED CAPITAL PLC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
ESG POLICY - CAMBRIDGE INNOVATION CAPITALCAMBRIDGE INVESTMENT RESEARCHCAMBRIDGE VENTURECIC CAMBRIDGE Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice.THE UK CFIUS REGIME
The UK CFIUS regime – what you need to know. Webinar: 8 June 2021, at 16.00-17.00. The UK government recently enacted the National Security and Investments Act, which is intended to give the government wide ranging powers to investigate deals on the grounds of nationalsecurity.
DR SOHAIB MIR PROMOTED TO PRINCIPAL Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, is delighted to announce that Dr Sohaib Mir has been promoted to Principal within the InvestmentTeam.
HOME - CAMBRIDGE INNOVATION CAPITAL - CIC Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. TEAM - CAMBRIDGE INNOVATION CAPITAL - CIC Dr March is passionate about mentoring, diversity, early career researchers and innovation in life sciences, establishing important collaborations with institutions such as the University of Cambridge, FinnGen and the Wellcome Sanger Institute. Osman Mardin. Osman Mardinis
PORTFOLIO - CAMBRIDGE INNOVATION CAPITAL - CIC Portfolio. Carol Cheung. Principal. Carol is a Principal focusing on a range of technology investments. Prior to joining CIC she worked in a variety of roles at several UK-based early stage tech companies, most recently as Commercial Director of Speechmatics, a Cambridge-based speech recognition start-up.ACCELERATORS
CIC has been working closely with stakeholders in the ecosystem to establish new accelerators, the first of which is Start Codon for life sciences and healthcare businesses. The goal is to speed up the process of going from “bench to product” by compressing years of learning for many companies and researchers into a short, six-monthwindow.
START CODON CLOSES NEW £15 MILLION VENTURE FUND Start Codon closes new £15 million ($20 million USD) venture fund to translate life science innovation into successful companies. Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP (the “Fund”) at £15 million.The Fund will be used to support Start Codon’s offering to start-ups, which includes CAREERS - CAMBRIDGE INNOVATION CAPITAL - CICCAMBRIDGE INNOVATION CENTREUNITED CAPITAL PLC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
GYROSCOPE ANNOUNCES FIRST PATIENT DOSED IN PHASE II Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, today announced the initiation of the Phase II HORIZON trial evaluating GT005 in people with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The first patient to receive GT005 in HORIZON was enrolled and dosed in the United Statesby
ESG POLICY - CAMBRIDGE INNOVATION CAPITALCAMBRIDGE INVESTMENT RESEARCHCAMBRIDGE VENTURECIC CAMBRIDGE Since its inception, Cambridge Innovation Capital (CIC) has been aligned with positive environmental, social and governance (ESG) goals. With the implementation of this policy CIC is further strengthening and formalising this position with additional commitments to evaluate ESG risks and opportunities in its internal operations and investment practice.THE UK CFIUS REGIME
The UK CFIUS regime – what you need to know. Webinar: 8 June 2021, at 16.00-17.00. The UK government recently enacted the National Security and Investments Act, which is intended to give the government wide ranging powers to investigate deals on the grounds of nationalsecurity.
DR SOHAIB MIR PROMOTED TO PRINCIPAL Cambridge Innovation Capital plc (CIC), the venture capital investor focused on intellectual property rich technology and life science businesses in the Cambridge ecosystem, is delighted to announce that Dr Sohaib Mir has been promoted to Principal within the InvestmentTeam.
CIC - CAMBRIDGE INNOVATION CAPITAL Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. PRAGMATIC SEMICONDUCTOR SELECTED AS ONE OF THE FINALISTS Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vc CONTACT - CAMBRIDGE INNOVATION CAPITAL - CIC Contact. Cambridge Innovation Capital Hauser Forum 3 Charles Babbage Road Cambridge CB3 OGT +44 (0)1223 764875. enquiries@cic.vcNEWS & INSIGHTS
Inivata raises £4m to realise the potential of ctDNA analysis to improve cancer treatment through simple blood tests. Read news PDF. CIC News. 12 August 2014. Cambridge Innovation Capital announces first three investments from its £50 million Cambridge Cluster fund. Readnews PDF.
OUR VALUES - CAMBRIDGE INNOVATION CAPITAL How we conduct ourselves and how we do business is extremely important to everyone at CIC. We strive to be good citizens and successful business partners whilst achieving the best results. CMR SURGICAL ANNOUNCES 1,000 SURGERIES COMPLETED BY 2020. 25 November 2020. CMR Surgical announces 1,000 surgeries completed by Versius. Versius, the next-generation surgical robot has been used to successfully conduct over 1,000 surgical procedures in hospitals across Europe and Asia. Combining Versius with a wider digital ecosystem, including a clinical registry, opens the door toworking with
CAREERS - CAMBRIDGE INNOVATION CAPITAL - CIC Careers. Home. About us. At Cambridge Innovation Capital we have a clear sense of purpose: we enable visionaries to build global, category leading companies. O ur continuous growth and search for talented professionals means we’re always looking for exceptional people. People who get things done, who love working in teams, and whoenjoy
ASSOCIATE - TECHNOLOGY - CAMBRIDGE INNOVATION CAPITAL Associate – Technology. Employment type: Full time. Location: Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT, UK. About Cambridge Innovation Capital. Cambridge Innovation Capital (CIC) is a leading venture investor in Cambridge backing and building category-leadingdeep tech and
COMPLETION OF SERIES B FOR CONGENICA AND CHINESE Congenica has completed its recently announced Series B funding round with additional investments from new strategically important investors BGI Genomics (BGI), a recognized global leader in genomics, Healthlink Capital (Healthlink), another well-established China-based life-science investor and Future Planet Capital, a global innovationfund.
EXVASTAT BEGINS CLINICAL DEVELOPMENT PROGRAMME FOR Exvastat Ltd has begun a clinical pharmacology trial in healthy volunteers as part of the development programme to evaluate the use of repurposed imatinib for the treatment of Acute Respiratory Distress Syndrome (“ARDS”). TELL US WHETHER YOU ACCEPT COOKIES We use cookies to collect information to improve the performance of our website. To find out more about the type of cookies we use and how we use this information please review our cookie policy here . Alternatively you can manage your cookie preferences here.Accept
Search
* About us View About us's child pages* CIC
* Our values
* Careers
* Team View Team's child pages* Team
* Board
* Advisory Panel
* Portfolio View Portfolio's child pages* Technology
* Life Sciences
* Accelerators
* News & Insights View News & Insights's childpages
* CIC News
* Portfolio News
* Events
* Read
* Listen
* Watch
* Contact
* Investors
* Home
* About us View About us's child pages* CIC
* Our values
* Careers
* Team View Team's child pages* Team
* Board
* Advisory Panel
* Portfolio View Portfolio's child pages* Technology
* Life Sciences
* Accelerators
* News & Insights View News & Insights's childpages
* CIC News
* Portfolio News
* Events
* Read
* Listen
* Watch
* Contact
* Investors
Previous
> We focus on developing life science companies which are built to > succeed. We’re excited to have founding investor CIC support us > and our emerging world class businesses.Jason Mellad, CEO
Daniel Rooke, COO
> CIC’s support has enabled Riverlane to become a globally leading > software and algorithm company in the rapidly emerging field of > quantum computing Leonie Mueck, Chief Product Officer Steve Brierley, CEO and Founder Bek Simmons, Chief Operating Officer > PetMedix develops antibody therapeutics for dogs and cats. CIC’s > investment enables us to accelerate our program to make the drugs > our pets need and deserveTom Weaver, CEO
Jolyon Martin, Head of Business Development > CIC’s investment has helped us in our ambition to develop a > transformational medicine for the treatment of pulmonary artery> hypertension
Wei Li, Co-Founder
> We're enabling the rapid deployment of machine learning models so > organisations can tackle their most important challenges. CIC's deep > tech expertise and commercial acumen is the ideal support for our> mission.
Alex Housley, Founder and CEOClive Cox, CTO
> CIC immediately recognised the disruptive potential of > AudioTelligence’s audio processing technology. They were the ideal > founding partner for AudioTelligence, bringing strong commercial and > operational experience.Ken Roberts, CEO
> CIC’s backing enables us to compete on the global stage to realise > our bold vision of transforming healthcare through decentralisation Ralph Lamble, Chief Development OfficerHarry Lamble, CEO
> We are building the world’s smartest video platform. CIC has been > a rock steady partner who understands the challenges and needs of a > company with global ambitionsCharlie Horell, CEO
> CIC's support for our vision allowed us to develop world-leading > non-invasive diagnostic tests for cancer using liquid biopsies. Nitzan Rosenfeld, Co-Founder and Chief Scientific Officer > CIC’s investment will enable us to grow the PolyProx team and > further develop our technology. Our platform harnesses the cell’s > natural protein degradation machineries, allowing access to > hard-to-drug targets. Laura Itzhaki, Chief Scientific Officer > Undo's platform saves its customers large sums of money by > significantly reducing MTTR of software failures. CIC has been > instrumental in the scaling of our commercial operations. Dr Greg Law, Co-founder & CTO > Exvastat is developing a pioneering new treatment for Acute > Respiratory Distress Syndrome. CIC has strongly supported us with > advocacy as well as money. David Cavalla, Executive Director > CIC’s approach is a great fit with PragmatIC’s unique flexible > electronics platform and vision towards trillions of smart objectsScott White, CEO
> We are harnessing cutting-edge RNA epigenetic enzyme technology to > develop first in class drugs. CIC’s expertise and collaborative > approach has been vital to the development of our company. Tony Kouzarides, Founder & Director Eric Miska, Founder & Director > Our revolutionary sound recognition technology brings contextual AI > to machines. CIC has deep domain expertise and relationships which> are invaluable
Chris Mitchell, CEO & Founder > Secondmind optimizes the most important activity at any company: > decision-making. CIC is one of our most trusted and valuable> partners
Vishal Chatrath, Co-Founder > We believe in building sustainable collaborative partnerships. CIC > has been a constant, constructive investor during our rapid growthCo-Founders:
Martin Frost, Co-Founder Paul Roberts, Co-Founder Keith Marshall, Co-Founder > GeoSpock are creating an operating system for the physical world in > which CIC have been a trusted partner in helping us to achieve> success
Steve Marsh, Founder, CEO & CTO > CIC have extensive experience investing in the digital > transformation of global energy systems and saw the potential for > Origami’s technology platform to lead this transformation in the> UK and beyond
Peter Bance, CEO
Next
WE ENABLE VISIONARIES TO BUILD GLOBAL, CATEGORY-LEADING COMPANIES Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem.About us
HIGHLIGHT
CIC announces acquisition of portfolio company InivataLearn more
PORTFOLIO
Cambridge Innovation Capital invests in some of the most exciting, forward-thinking companies across the technology and life sciencessectors.
Portfolio Portfolio NewsTEAM
Meet our team
LATEST NEWS
*
1 June 2021
Portfolio News
CMR Surgical becomes the official Medical Device Partner ofParalympicsGB
*
31 May 2021
Portfolio News
CMR Surgical collaborates with Microsoft in a pioneering new trial for health data storage*
5 May 2021
CIC News
Cambridge Innovation Capital announces acquisition of portfoliocompany Inivata
CIC news Portfolio newsPOPULAR LINKS
* Portfolio
* News & Insights
* Careers
* Investors
* Contact
CONTACT
Cambridge Innovation CapitalHauser Forum
3 Charles Babbage RoadCambridge
CB3 OGT
+44 (0)1223 764875
enquiries@cic.vc
Register here for CIC News Copyright ©2021 Cambridge Innovation Capital Cambridge Innovation Capital Manager Limited (FRN:918898) is authorised and regulated by the Financial Conduct Authority.* Cookie Policy
* Cookie preferences* ESG Policy
* Sitemap
* Website Terms of Use* Privacy Policy
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0